Skip to main content
SpringerLink
Log in

The Effects of FeCl3 and Fe–EDTA on the Development of Psoriasis

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The effects of FeCl3 and Fe–EDTA on the development of psoriasis were studied in the mouse model of vaginal epithelium and tail epidermis. The mitoses of vaginal epithelial cell in female mice of their estrogenic stage and the formation of granular cell layers in male mouse tail scale were observed. Mice were randomly divided into eight groups and treated with normal saline, methotrexate, and different doses of two iron forms, FeCl3 and Fe–EDTA, respectively, for 10 days. To explore the influence of FeCl3 and Fe–EDTA on the excretion of Cu, Fe, Zn, Ca, Mg, Mn, and Se, the concentration of those elements in liver and kidney was analyzed by atomic absorption spectrometry. The different doses of FeCl3 or Fe–EDTA could obviously inhibit the mitoses of vaginal epithelial cell (p< 0.05) and promote the formation of granular cell layers in mice tail scale (p < 0.05). No statistically significant results were found between the groups of FeCl3 and Fe–EDTA, and between experimental groups and methotrexate group acted as the positive control (p>0.05). Compared with the negative group, the concentrations of Cu, Fe, Zn, Ca, Mg, Mn, and Se in liver and kidney of experimental groups and positive control group were not significantly changed (p > 0.05). FeCl3 and Fe–EDTA are as effective as methotrexate on inhibiting hyperplasia of epidermal cells and increasing the formation of granular cell layers, and the concentrations of Cu, Fe, Zn, Ca, Mg, Mn, and Se in liver and kidney of experimental groups and positive control group were not significantly changed compared with the negative group, possibly retarding the development of psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. DiSepio D, Chandraratna RA, Nagpal S (1999) Novel approaches for the treatment of psoriasis. Drug Discov Today 4(5):222–231

    Article  PubMed  CAS  Google Scholar 

  2. Serwin AB, Wasowica W, Gromadzinska J, Chodynicka B (2003) Selenium status in psoriasis and its relations to the duration and severity of the disease. Nutrition 19(4):301–304

    Article  PubMed  CAS  Google Scholar 

  3. Julia T, Mamelak AJ, Sauder DN (2006) Current advancements in the treatment of psoriasis. Clin Appl Immunol Rev 6(5):465–483

    Google Scholar 

  4. O'Neill JL, Kalb RE (2009) Ustekinumab in the therapy of chronic plaque psoriasis. Biologics 3:159–168

    PubMed  Google Scholar 

  5. Pastore S, Gubinelli E, Leoni L (2008) Biological drugs targeting the immune response in the therapy of psoriasis. Biologics 2(4):687–697

    PubMed  CAS  Google Scholar 

  6. Ding ZY, Sun XJ (2003) Trace elements determination of psoriasis patients’ serum. J Clin Dermatol 32(9):525

    Google Scholar 

  7. Hu TZ, Zhang Y (1999) Five trace elements determination of psoriasis patients’ hair. Chinese journal of leprosy skin 19(1):40–41

    Google Scholar 

  8. Finzi AF (1994) Update on nutrition and psoriasis. Int J Dermatol 33(7):523

    Article  PubMed  CAS  Google Scholar 

  9. Keszthelyi B, Kiss AM, Tóth A (1976) Iron absorption and loss in psoriasis. Acta Med Acad Sci Hung 33(2):125–131

    PubMed  CAS  Google Scholar 

  10. Zhang JH (2009) Effect of the combination of intravenous iron with reduced glutathione hormone supplementation on oxidative stress in hemodialysis patients. Anhui Med J 30(9):1062–1064

    Google Scholar 

  11. Bonder RH, Van Scott EJ (1971) Use of mouse vaginal and rectal epithelium to screen antimitotic effects of systemically administered drugs. Cancer Res 31(6):851–853

    PubMed  CAS  Google Scholar 

  12. Jarrett A (1973) The physiology and pathophysiology of the skin. Lancet 2(7826):45

    Google Scholar 

  13. Zhao HT, Yao L, Wang J (2007) Research on security of iron-glycine and functional experiment. Food Res Dev 28(12):5–7

    Google Scholar 

  14. Patel RV, Clark LN, Lebwohl M, Weinberg JM (2009) Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol 60(6):1001–1017

    Article  PubMed  Google Scholar 

  15. Mendonca CO, Burden AD (2003) Current concepts in psoriasis and its treatment. Pharmacol Ther 99(2):133–147

    Article  PubMed  CAS  Google Scholar 

  16. Basavaraj KH, Darshan MS, Shanmugavelu P (2009) Study on the levels of trace elements in mild and severe psoriasis. Clin Chim Acta 405(1–2):66–70

    Article  PubMed  CAS  Google Scholar 

  17. Cao GH, Chen JL (1999) The impact of iron deficiency and supplementation on lipid peroxidation and superoxide dismutase enzyme. Chin Med 71(9):623

    Google Scholar 

  18. Cao JQ, Cui R (2005) Trace elements determination of psoriasis patients’ serum. China J Lepr Skin Dis 8(21):617–618

    Google Scholar 

  19. Ghosh A, Mukhopadhyay S, Kar M (2008) Role of free reactive iron in psoriasis. Indian J Dermatol Venereol Leprol 74(3):277–278

    Article  PubMed  Google Scholar 

  20. Leveque N, Robin S, Muret P (2004) In vivo assessment of iron and ascorbic acid in psoriatic dermis. Acta Derm Venereol 84(1):2–5

    Article  PubMed  CAS  Google Scholar 

  21. Sato S (1991) Iron deficiency: structural and microchemical changes in hair, nails, and skin. Semin Dermatol 10(4):313–319

    PubMed  CAS  Google Scholar 

  22. Kurz K, Steiqleder GK, Bisebof W (1987) PIXE analysis in different stages of psoriatic skin. JInvest Dermatol 88(22):23–26

    Google Scholar 

  23. Mateus C, Franck N, Leclerc S (2007) Vulvar dermatitis and iron deficiency. Ann Dermatol Venereol 134(1):45–47

    Article  PubMed  CAS  Google Scholar 

  24. Satos S (1991) Iron deficiency: structural and microchemical changes in hair, nails, and skin. Semin Dermatol 10(4):313–319

    Google Scholar 

  25. Rosenthal NS, Farhi DC (1999) Bone marrow findings in connective tissue disease. Am J Clin Pathol 92(5):650–654

    Google Scholar 

  26. Zhang X, Guo DM, Lin XY, Cui X (2006) Analysis on absorption rate of iron and calcium in representive diets of children in rural area of Shandong province. Chinese Journal of Public Health 22(5):555–556

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of medicine, Dezhou College, Dezhou, Shandong, China

    Qiang Shi

  2. Institute of Chemistry and Bacteria Detection, College of Public Health, West Campus of Shandong University, Jinan, China

    Xiao-qian Yang & Xi Cui

Authors
  1. Qiang Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao-qian Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xi Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xi Cui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shi, Q., Yang, Xq. & Cui, X. The Effects of FeCl3 and Fe–EDTA on the Development of Psoriasis. Biol Trace Elem Res 140, 73–81 (2011). https://doi.org/10.1007/s12011-010-8671-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-010-8671-8

Keywords

Search

Navigation